Deal sells units of one common share and one warrant at $1.00 per unit
By Devika Patel
Knoxville, Tenn., Aug. 4 – Enumeral Biomedical Holdings, Inc. said it raised $21.5 million through a private placement of units.
The company sold 21.5 million units of one common share and one warrant at $1.00 per unit. The warrants are each exercisable at $2.00 for five years.
The financing was led by Montrose Capital Partners and included participation by founding investor Harris & Harris Group, Inc. EDI Financial was the lead placement agent.
The company also said it completed a merger between Enumeral Biomedical Corp. and a company subsidiary, formerly known as Cerulean Group, Inc.
The company develops immunotherapies that help the immune system attack diseased cells.
Issuer: | Enumeral Biomedical Holdings, Inc.
|
Issue: | Units of one common share and one warrant
|
Amount: | $21.5 million
|
Units: | 21.5 million
|
Price: | $1.00
|
Warrants: | One warrant per unit
|
Warrant expiration: | Five years
|
Warrant strike price: | $2.00
|
Agent: | EDI Financial (lead)
|
Investors: | Montrose Capital Partners (lead), Harris & Harris Group, Inc.
|
Settlement date: | Aug. 4
|
Stock symbol: | OTCBB: ENUM
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.